Sharemaestro Newsreel

TriSalus Life Sciences (TLSI) Stock Surges As Losses Deepen Behind Strong Margins

TriSalus Life Sciences (TLSI) stock surged 15.2% despite the company reporting deeper losses in Q2 2026, with a net loss of US$9.2m and an adjusted EBITDA loss of US$7.1m. While revenue remained flat at US$11.4m, the gross margin improved to 86.8%, indicating strong unit …

Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum

Tandem Diabetes Care (TNDM) saw its stock rise 14.8% after reporting record Q2 2026 worldwide sales of US$254.56 million, a higher gross margin, and a reduced net loss, while reaffirming its full-year sales guidance of US$1.07 billion. The company's new PayGo pharmacy model, which …

Senseonics Holdings Inc. R (6L60.DU) stock price, news, quote and history

This Yahoo Finance page provides comprehensive information on Senseonics Holdings Inc. R (6L60.DU), including its current stock price, recent news headlines, and historical performance data. The stock closed at 6.65 EUR, up 4.72%, on August 11th, 2026. News highlights cover earnings reports, analyst ratings, …

Bioventus (BVS) Is Up 6.1% After Reaffirming 2026 Sales Outlook And Strong Q2 Earnings Jump

Bioventus Inc. (BVS) reported strong Q2 2026 results with a significant jump in net income and reaffirmed its full-year 2026 sales guidance of US$600 million to US$610 million. The company's investment narrative focuses on converting modest sales growth into higher profitability while managing debt. …

Outset Medical Number of Employees 2026 | Employee Count & Headcount Data

Outset Medical, Inc. (NASDAQ: OM) had 308 employees worldwide as of March 2026, representing a 33.2% decline from 2023. The company is actively hiring, with 53 job postings in 2026. Its workforce is primarily in North America (67.5%), and the average salary is $112,809.

Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results

Tandem Diabetes Care (TNDM) reported strong Q2 2026 results with record worldwide sales and reaffirmed full-year guidance, leading to a significant rally in its share price. Despite the recent gains, Simply Wall St. suggests that TNDM is still undervalued by 23.4%, with a fair …

AptarGroup, Inc. (ATR) Stock Forecasts

Argus has lowered its target price for AptarGroup, Inc. (ATR) to $150.00 from its current price of $135.42. AptarGroup, headquartered in Crystal Lake, Illinois, is a leading global supplier of dispensing systems for consumer goods and pharmaceutical markets. The report was published on August …

Earnings Preview: SRTS to Report Financial Results Post-market on August 13

This article announces that Sensus Healthcare (SRTS) is expected to report its financial results after market close on August 13. The company is scheduled to host a conference call and webcast on August 14 to discuss these results.

Gradient Investments LLC Sells 126,411 Shares of Abbott Laboratories $ABT

Gradient Investments LLC reduced its stake in Abbott Laboratories (ABT) by 34.9% in Q2 2026, selling over 126,000 shares but still retaining a significant holding worth $21.4 million. Despite this sale, institutional investors collectively own 75.18% of ABT. The company recently exceeded quarterly earnings …

Arrowstreet Capital Limited Partnership Acquires 393,310 Shares of Inogen, Inc $INGN

Arrowstreet Capital Limited Partnership significantly increased its stake in Inogen, Inc. by 203.9% in the first quarter, purchasing 393,310 additional shares, bringing its total holdings to 586,159 shares. This makes Arrowstreet Capital own 2.16% of the medical technology company, with institutional investors collectively holding …

Alphatec Holdings (ATEC) Earnings And Guidance Keep Valuation In Focus

Globus Medical (GMED) Stock Leans On Margin Gains As Nevro Recovery Lags

Globus Medical (GMED) reported a strong Q2 2026 with record non-GAAP earnings per share and a high adjusted EBITDA margin, indicating significant margin strength. Despite these gains, the company faces challenges with Nevro sales declining and robotics adoption being slower than anticipated, leading to …

Why UFP Technologies (UFPT) Is Up 23.2% After Stronger Q2 2026 Revenue And Earnings Performance

UFP Technologies (UFPT) reported strong Q2 2026 results with sales of US$173.96 million and net income of US$20.85 million, leading to a 23.2% stock increase. The company's first-half performance shows increased profitability and sales, supporting its investment narrative focused on operational efficiency and strategic …

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Medtronic and Intuitive Surgical, two leading medical device companies, have faced challenges this year but are poised for a rebound. Medtronic offers a strong dividend yield and diversified product portfolio, while Intuitive Surgical leads the robotic-assisted surgery market with its innovative da Vinci system. …

Globus Medical (NYSE:GMED) Releases Earnings Results, Beats Expectations By $0.24 EPS

Enovis (NYSE:ENOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Enovis (ENOV) reported Q2 earnings of $0.9 per share, exceeding the Zacks Consensus Estimate of $0.83, and revenues of $582.78 million, also surpassing estimates. The company has consistently beaten EPS estimates over the last four quarters and revenue estimates three out of the last …

Integer Holdings Corp (ITGR) News, Articles, Events & Latest Updates

Integer Holdings Corp (ITGR) has been in the news due to its Q2 earnings exceeding estimates, a proposed acquisition by KKR for $5.7 billion, and several shareholder alerts regarding the fairness of the deal. Multiple law firms are investigating whether the proposed sale price …

VAREX IMAGING Q3 2026 Earnings Preview: Recent $VREX Insider Trading, Hedge Fund Activity, and More

TACTILE SYSTEMS TECHNOLOGY Q2 2026 Earnings Preview: Recent $TCMD Insider Trading, Hedge Fund Activity, and More

Avita Medical (NASDAQ:RCEL) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Avita Medical (NASDAQ:RCEL) announced its quarterly earnings, beating analyst estimates with an adjusted loss of $0.25 per share on revenue of $21.7 million. The company's revenue increased 18% year-over-year, driven by strong RECELL sales, and management raised its 2026 revenue guidance. Avita Medical expects …

Irhythm Technologies Boosts Outlook, Expands Cardiac Monitoring Platform

iRhythm Technologies (IRTC) recently settled a patent dispute for $50 million and announced strong Q2 2026 results, including a 20.1% revenue increase and improved margins. The company also secured FDA clearance for a new algorithm and plans to acquire Vital Connect for $287.5 million …

Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Inogen (NASDAQ:INGN) reported quarterly earnings, beating expectations with a loss of $0.14 per share against a projected $0.15 loss. While revenue slightly missed estimates at $95.08 million, the company showed improved profitability with a 15% rise in adjusted EBITDA and strong international sales growth. …

Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART

Quantinno Capital Management LP significantly reduced its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 45.4% in the first quarter of 2026, selling 382,663 shares. Despite this reduction, other institutional investors like Paradigm Capital, Sei Investments, and Walleye Capital increased their holdings, maintaining high …

PROCEPT BioRobotics Corp. Revenue Breakdown – BMV:PRCT

PROCEPT BioRobotics Corp. (BMV:PRCT) generated 5.55 billion MXN in revenue last year. The "Hand Pieces and Other Consumables" segment was the top performer, contributing 3.27 billion MXN, an increase from 2.53 billion MXN the previous year. The United States was the primary revenue source, …

Rapid Micro Biosystems, Inc. (RPID) Leadership & Management Team Analysis

This article provides an in-depth analysis of Rapid Micro Biosystems, Inc. (RPID)'s leadership, management team, and recent company updates. It highlights CEO Rob Spignesi's compensation and ownership, along with details on insider transactions, board changes, and financial risks. The company faces challenges such as …

Earnings Preview: LENSAR to Report Financial Results Pre-market on August 13

This article provides an earnings preview for LENSAR (NASDAQ: LNSR), which is scheduled to release its Q2 2024 financial results before the market opens on August 13, 2024. The company has a history of beating EPS estimates but missing revenue forecasts. Investors will be …

AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS) is investigating potential securities law violations by AdaptHealth Corp. (NASDAQ: AHCO) on behalf of its investors. This investigation follows AdaptHealth's Q2 2026 financial results, where the company missed earnings estimates and significantly cut its full-year guidance, leading to …

Apyx Medical Corporation (NASDAQ:APYX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Apyx Medical Corporation (NASDAQ:APYX) has received a "Moderate Buy" consensus recommendation from seven brokerages, with an average 12-month price target of $6.60, significantly higher than its current $4.05 price. The company recently surpassed earnings estimates, reporting a smaller adjusted loss and higher revenue than …

Medtronic PLC (MDT) Stock Analysis & Forecast

This article provides an analysis and forecast for Medtronic PLC (MDT) stock. It includes recent stock performance data, key financial metrics, and mentions two in-depth analyses published by TradingKey. These analyses cover broader market trends and Medtronic's strategy for capitalizing on the aging global …

Neogen Corporation (NEOG) Stock Forecasts

Argus has raised its target price for Neogen Corporation (NEOG) to $12.00, citing the company's focus on food and animal safety products. Neogen, based in Lansing, Michigan, develops, manufactures, and markets these products. The report provides a summary of the company and suggests upgrading …

NovoCure (NASDAQ:NVCR) Rating Increased to Buy at Wall Street Zen

Wall Street Zen has upgraded NovoCure (NASDAQ:NVCR) to a "Buy" rating, despite a broader analyst consensus of "Hold" with an average price target of $21.20. The upgrade follows NovoCure's strong quarterly results, where adjusted EPS loss of $0.13 significantly beat the anticipated $0.33 loss, …

Artivion (AORT) Stock Can Revenue Growth Outrun Fresh Losses?

Artivion (AORT) saw its stock edge up slightly despite a mixed Q2 2026 earnings report, which showed strong revenue growth but a swing back to a net loss. The company's aortic franchise, particularly with AMDS approval and growth in On X valves, fuels the …

Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lifeward Ltd (LFWD) has an earnings forecast score of 8.00, ranking 65th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $4.50, with a high of $10.00 and a low of $1.00. Based on ratings from two analysts, …

908 Devices | 4: Statement of changes in beneficial ownership of securities-Director Brown Christopher D.

This document is a statement of changes in beneficial ownership of securities for Director Christopher D. Brown of 908 Devices. It reports transactions related to his holdings in the company.

CONMED (CNMD) Lifts Sales Outlook, Is The Stock 24% Overvalued?

LivaNova (LIVN) Rebounds On Earnings As The Bull Case Points To More Upside